SPSananda Pati

Sananda Pati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sananda Pati has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Emilee Das

    Department of Paediatric Medicine, IPGMER and SSKM Hospital, Kolkata, West Bengal, India

    3 shared publications
  • Mrinal Kanti Das

    Department of Pediatrics, IPGME&R, Kolkata, West Bengal, Kolkata, India

    3 shared publications
  • Norbu Sherpa

    Department of Pediatric Medicine, Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, India

    2 shared publications
  • Sangita De

    Department of Paediatrics, Burdwan Medical College and Hospital, Burdwan 713104, West Bengal, India

    2 shared publications
  • Soumyadeep Sarkar

    Department of Pediatric Medicine, Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, India

    2 shared publications
  • Supratim Datta

    Department of Pediatric Medicine, Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital, Kolkata, India

    2 shared publications

Latest Publications

  • Open Access

    Clinico-epidemiological profile and long-term follow-up of IgA vasculitis in children admitted in a tertiary care hospital in Eastern India

    by Norbu Sherpa, Sananda Pati, Supratim Datta

    Background: IgA vasculitis is the most common systemic vasculitis seen in children.Objectives: To assess the clinical and epidemiological profile of IgA vasculitis in children admitted in a tertiary care centre, the short-term outcome at 6 months and the long term follow up of this cohort for 2 years.Method: A hospital based prospective, observational study was conducted at the Department of Paediatric Medicine of a tertiary care hospital in Eastern India. IgA vasculitis patients fulfilling European League against Rheumatism (EULAR) criteria were enrolled from February 2021 to August 2022 and were subsequently followed up for a period of 2 years. Results: A total of 33 children aged 1-12 years was enrolled; 3 were excluded due to alternate diagnosis. Male to female ratio was 1:1. The mean age was 7.6 ± 2.33 years; 40% of cases occurred in winter; 53.3% were from rural areas. Clinical features noted were purpuric rashes (100%), arthralgia (46.6%), arthritis (26.6%), renal manifestations (13.3%) and testicular swelling (3.3%). Among the four Henoch-Schonlein Purpura (HSP) nephritis cases, 2 had isolated microscopic haematuria, and 2 had nephritic syndrome. Renal biopsy was done in two (6.6%) and showed HSP nephritis Class 1. Seven (23.2%) patients received pulse methyl prednisolone, six for upper gastrointestinal bleeding and one for orchitis; 13.3% had hypertension and renal involvement during 6 month follow up; 16.6% showed recurrence of rash. Up to 6 recurrences were noted during the 2-year follow-up period; 11 patients could be followed up to 2 years.Conclusions: Male to female ratio was 1:1. Mean age was 7.6 ± 2.33 years. Common clinical features were purpuric rashes (100%), arthralgia (46.6%), arthritis (26.6%) and renal manifestations (13.3%). Seven (23.2%) patients received pulse methyl prednisolone. Recurrence of rash occurred in 16.6%.

  • Open Access

    Moyamoya Disease: A Cerebrovascular Involvement in a Child with Wiskott–Aldrich Syndrome

    by Emilee Das, Sananda Pati, Saherin Jesmin, Abhik Paul

    Background: Wiskott–Aldrich syndrome (WAS) is a rare X-linked disorder characterized by immunodeficiency, thrombocytopenia, and eczema, with a risk of autoimmune phenomena. Clinical Description: A 3-year-old boy presented to us with a history of recurrent skin and mucosal bleeds, itchy skin lesions, and recurrent purulent ear discharge. He had been hospitalized for pneumonia and meningitis earlier, having developed left-sided hemiplegia associated with a cerebral infarct. On examination, he was growth retarded with pallor, hepatosplenomegaly, multiple purpuric spots, and infected scalp lesions. In addition, he had spastic hemiparesis in the left side. Management and Outcome: Investigation revealed microcytic hypochromic anemia, eosinophilia, thrombocytopenia, and very high IgE titer (10,433). Coagulation profile was normal. Tuberculosis work-up was negative. The mean platelet volume was low normal (7.3) and bone marrow showed decreased number and size of megakaryocytes. Exome sequencing showed pathogenic mutation of WAS gene in exon 3 hemizygous XLR variant. The patient received weekly intravenous immunoglobulin therapy and cotrimoxazole. The eczema, thrombocytopenia, and infections improved. Later, he developed sudden-onset bilateral loss of vision. Magnetic resonance (MR) imaging brain revealed acute infarct on the left occipital region and gliosis in the right cerebral hemisphere with MR angiography showing middle and posterior cerebral artery thrombosis and narrowing of bilateral distal internal carotid arteries suggestive of moyamoya disease. Immunosuppressive agents and antiplatelets could not be administered, so the child was kept under supportive care. Conclusion: This case makes pediatricians aware of the possibility of cerebrovascular events as a manifestation of autoimmune vasculitis in children with WAS. Optimal treatment for such cases needs research.

  • Open Access

    A mysterious hematochezia in an adolescent boy: atypical presentation of childhood systemic lupus erythematosus

    by Abhik Paul, Sandeep Ghosh, Saherin Jesmin, Sananda Pati

    Thrombosis is a well-known entity in presence of antiphospholipid antibody (APLA) associated with systemic lupus erythematosus (SLE) as a hematological complication. Bleeding manifestations instead of thrombosis is hardly found in literature in presence of APLA seromarkers in SLE. Since these can range from minor bleeding like epistaxis to major life-threatening intracranial bleeding, early diagnosis and prompt treatment is essential to manage such condition. We report a 12 years old boy with no significant past history presented with hematochezia and epistaxis along with pallor requiring blood transfusion. Hematological investigations were normal except for elevated PT, aPTT and INR. Common causes of coagulopathy were ruled out. Upon suspecting systemic diseases, the investigations were carried out which revealed ANA 4+ along with high titre of dsDNA, low C3 and C4 complement and positive anti-β2 glycoprotein, anticardiolipin antibody and lupus anticoagulant. Diagnosis of SLE was made according to ACR-EULAR criteria with no renal involvement. Immunological basis was considered for coagulopathy in this child. He was started on oral prednisolone, hydroxychloroquine and methotrexate. He is now under close monitoring of the coagulation profile for titration of steroid dose. We want to create awareness about the uncommon hematological manifestation of SLE presenting as bleeding diathesis instead of thrombosis through this case report and that can be life threatening too if not treated promptly. A high index of suspicion and careful follow-up may help in preventing adverse outcome of the disease.

  • Open Access

    Anti –NMDA receptor encephalitis in children: A study from Eastern India

    by Sananda Pati, Mrinalkanti Das, Arpan Saha, Ranjabati Datta, Soumi Bag, Saraswati Mondal

    Introduction: Anti-N-methyl-d-aspartate receptor (Anti-NMDAr) encephalitis is the second common cause of autoimmune encephalitis.Objectives: To describe the clinico-epidemiological profile, treatment, and outcome of paediatric anti-NMDAr encephalitis patients.Method: This is a retrospective, observational study in a tertiary care hospital from eastern India with 16 anti-NMDAr encephalitis cases aged <12 years. All patients were positive for cerebrospinal fluid (CSF) anti NMDAr antibody. Graus criteria were used for case detection and modified Rankin scale for assessing neurological disability before and after treatment. All cases received first line immunotherapy with intravenous immunoglobulin (IVIG), methyl prednisolone or both; those with failure to respond or worsening were considered for second line immunotherapy.Results: The 16 patients were aged 6 months to 11 years (mean 7.7 years); 43.8% were female; they were diagnosed by an average 25 days; speech defects (93.8%), psychiatric manifestations (100%) and seizures (87.5%) were the early features. CSF anti NMDAr antibody was positive in 100% and electro-encephalographic (EEG) changes were found in 100%. There were no tumours in pelvis or abdomen on ultrasonography. Magnetic resonance imaging abnormalities were present in 62.5%. First line immunotherapy consisting of only IVIG (18.8%), only methyl prednisolone (6.25%) and both IVIG and methyl prednisolone (75%) was started by a median 30 days, with better response in the latter group. Seven (43.8%) patients received second line immunotherapy (Rituximab) with prompt response Twelve (75%) cases are under regular follow up. Oral prednisolone was continued for one year in the initial 8 cases. In the remaining 4 cases, steroids were tapered when serum anti NMDAr antibody became negative. Relapse was noted in one case.Conclusions: Speech defects (93.8%), psychiatric manifestations (100%) and seizures (87.5%) were early features. Positive CSF anti NMDAr antibody and EEG changes were found in 100%. First line immunotherapy consisted of IVIG and methyl prednisolone.Sri Lanka Journal of Child Health, 2022; 51(4): 513-518

  • Frightening Fever: Familial Cold Autoinflammatory Syndrome 2 (FCAS-2) with Macrophage Activation Syndrome (MAS)

    by Sananda Pati, Soumyadeep Sarkar, Emilee Das, Norbu Sherpa, Mrinal Kanti Das, Supratim Datta


  • Kaposiform Hemangioendothelioma with Kasabach–Merritt Phenomenon

    by Sananda Pati, Mrinal Kanti Das, Akshay Rana, Emilee Das, Soumyadeep Sarkar, Norbu Sherpa, Supratim Datta

    A 3-y-3-mo old male child presented with massive hypertrophy and bluish-purple discoloration of the left upper limb and adjacent chest wall of 3 mo duration. There was no h/o fever, weight loss, painful large joint swelling, or any bleeding manifestations. He had spindle like nonprogressive, painless swelling of all fingers of the left hand since infancy. The child was moribund with microangiopathic hemolytic anemia, thrombocytopenia, and consumptive coagulopathy without sepsis. He received multiple transfusions of fresh frozen plasma (FFP), platelets, and packed RBC. Paradoxical worsening of symptoms with platelet transfusions and radiological evidences led to the diagnosis of a very rare congenital multifocal vascular tumor, kaposiform hemangioendothelioma (KHE) with Kasabach–Merritt phenomenon (KMP). The index case of KHE was multifocal with cutaneous lesions, osteolytic bony lesions of all phalanx and metacarpals of the left hand, and intrathoracic extension. It was successfully managed with a combination of steroid, vincristine and sirolimus.


  • Multifocal pure tubercular osteomyelitis: An unusual presentation in childhood

    by Sananda Pati, Sangita De, Tarak Nath Ghosh, Mrinal Kanti Ghosh


  • Open Access

    Miller Dieker Syndrome as a Cause of Refractory Seizures

    by Sananda Pati, Sangita De, Sankha Subhra Nag, Kaustav Nayek

    Miller-Dieker syndrome is a genetic deletion syndrome characterized by neuronal migration disorder lissencephaly where the exterior of the brain is abnormally smooth with fewer folds and grooves and characteristic facial dysmorphism. A one year old boy born presented to our emergency with severe respiratory distress and recurrent convulsions. A diagnosis of Miller Diecker syndrome was made consistent with typical clinical features and investigations. The child was managed symptomatically, however the seizures remained refractory and the child succumbed on day three of admission. Diagnosis of rare diseases like this is necessary not only for management but also for predicting recurrence in the family and genetic counselling. Key words: Miller Dieker syndrome; Lissencephaly; Refractory Seizures DOI: http://dx.doi.org/10.3126/jnps.v34i2.9408J Nepal Paediatr Soc 2014;34(2):154-156